brdta1zhi9newra_UserUpload.Net

<25

Lung cancer incidence
(Rate per 100,000, 2017)

25-30

30-35

35-40

40-45

>45

France

Scorecard results

Indicator Range Score Justification

Lung cancer is a strategic priority

1 Operational,

comprehensive, up to

date national cancer

control plan

0 – 5 3  Plan Cancer 2014-2019 was published by the Ministry of Social Affairs and Health and the

Ministry of Higher Education and Research in 2014.^6

 The plan includes an overarching implementation plan.

 A funding source has not been identified within the plan.

 A specific lung cancer control plan has not been published by the government or health

ministry.

2 Comprehensive clinical

guidelines for lung

cancer

0 – 6 5  The High Authority of Health published the lung cancer guidelines in 2013 and 2014.^7

 The guidelines mention diagnosis, treatment, supportive / palliative care and shared

decision-making.

 The guidelines do not mention screening. However, the Haute Authorité de Santé (HAS)

published in January 2016 an opinion about lung screening and concluded that screening

isn’t recommended due to safety and efficacy.

Lung cancer is a public health issue

3 Tobacco control policies

and public health

measures

0 – 9 8  National objectives on tobacco control and a national agency for tobacco control exist.^8

 France is party to World Health Organization (WHO) Framework Convention on Tobacco

Control (FCTC).

 Advertising is banned on national TV and radio.

 Law mandates that health warnings appear on tobacco packages.

 At least one national mass media campaign ran during the survey period (up to 2016).

 National smoke-free legislation exists for indoor offices, restaurants/cafes/pubs/bars and

public transportation.

4 E-cigarettes regulation

and public health

measures

0 – 4 4  Safety, quality standards and regulation are in place for e-cigarettes.

 The sale of e-cigarettes is prohibited to people under 18 years of age.

 Advertising, promotion and sponsorship related to both nicotine and non-nicotine

e-cigarettes are prohibited.

 Use of e-cigarettes is prohibited on public transport, enclosed workplaces (as defined by

an application decree) and areas with minors.

5 National policies

and programmes for

environmental exposure

control

0 – 2 2  The Plan National de Surveillance de la Qualite de l’Air Ambient (PNSQA) 2016-2021 defines

the organisational, technical and financial structure of the national air quality monitoring

system for the period 2016-2021.

 A decree passed in April 2017 lays down provisions for applying the national air quality

monitoring system.

 The Instut de radioprotection et de sûreté nucléaire (IRSN) published a report on radon

and the WHO cited France's radon control programme.

6 Evidence-based

approach to lung cancer

screening

0 – 1 1  A pilot randomised controlled trial of low dose computed tomography screening was

launched in 2002.

7 Patient organisations

involvement in policy

development

0 – 3 3  Lung cancer patient organisations exist in France.

 Lung cancer guidelines were prepared with participation of a patient representative.

 Patients are involved in Health Technology Assessments (HTAs).

Lung cancer is a race against time

8 Suspected lung cancer

patient diagnosis within

a specific time frame

0 – 2 0  Lung cancer guidelines neither mention the fast tracking nor any specific timeframe for

diagnostic referral for suspected lung cancer patients.

9 Guidelines/ pathways for

rapid referral to quality

care

0 – 2 1  Lung cancer guidelines do not mention rapid referral for lung cancer patients to secondary

or tertiary care.

 Multidisciplinary teams are mentioned in the lung cancer guidelines to guide treatment

plans.